Title: Executive Director & Chief Scientific Officer Workplace: ChristianaCare Gene Editing Institute & CorriXR Therapeutics Alma Maters: Rutgers University, Southern Illinois University, University of Florida School of Medicine Boards: Philadelphia-Israel […]
CorriXR Therapeutics, the gene-editing drug firm spun out of ChristianaCare, has turned to biotech veteran Deborah Moorad, as its new CEO.
Nature makes mistakes, even with our human genetic makeup. Not surprisingly, since discovery of the DNA double helix 70 years ago, scientists of various disciplines have been searching for ways […]
CorriXR Therapeutics, the gene-editing cancer drug firm spun out of ChristianaCare, won the Delaware DNA pitch contest of promising startups.
WILMINGTON — ChristianaCare has spun out its first commercial biotech company focused on gene-editing technology to develop new cancer treatments. CorriXR Therapeutics launched Tuesday with $5 million in seed funding […]
Premier Digital Partners
© 2024 Delaware Business Times
